BIO - Bio-Rad
$300.45 -11.42 (-3.66%)
Updated: 03:15 May 5, 2024 ESTNext Hour's AI Forecast
97.81%
Avg. Accuracy (AI)
$262.74
Next Session's AI Forecast
93.82%
Avg. Accuracy (AI)
$301.91
Next Week's AI Forecast
0%
Trend's Accuracy (AI)
$314.98
| Rank (0-100) |
| Rank (0-100) |
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0.96 | -0.75 | -0.2 | -0.02 | -0.1 |
|---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0.96 | 1.85 | 1.45 | 1.37 | 1.34 |
|---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
| Curr. Week | Next Week | Curr. Month | Curr. Quarter | 100% | 100% | 17.52% | 14.86% |
|---|
MOVING AVERAGE METRIC
| 5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 280.94 | 0.98% | 278.22 | -9.48% | 307.36 | -2.16% | 314.15 |
|---|
RSI METRIC
| RS Hour | RSI Hour | RS Day | RSI Day | 0.27 | 12.28 | 0.64 | 21.26 |
|---|
Bio-Rad Technical Analysis News
News About Bio-Rad in last three days
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 12.25% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
At May 7, 2024, 9:30 pm
Zacks
Mentions in the news over the last three days
In the last three days Bio-Rad was mentioned 1 times in 1 different publications.
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
"While Bio-Rad has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?"
At May 7, 2024, 9:30 pm
Zacks
Bio-Rad
1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com
| Sectors: | Healthcare |
| Industry: | Medical Devices |
| F. Time Employees: | 8030 |
Description
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Corporate Governance
Bio-Rad Laboratories, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 10; Compensation: 4.
List of holders with stock participation in Bio-Rad.
| Holder Rank | Holder | Shares | Date Reported | % Out | Value |
|---|